← United States · Coverage record
US · SEC FORM 4
CUMBERLAND PHARMACEUTICALS INC
CPIX · Nasdaq · CIK 0001087294 · Healthcare · Drug Manufacturers—Specialty & Generic
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
0 Form 4 transaction lines observed in the same window
0 sales · 0 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
No Form 4 transaction event is present in the current 180-day window.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-08-29 · Young Caroline.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 348,880
- Previous report
- 252,451
- Avg daily volume
- 46,316
- Days to cover
- 7.5
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2025-08-29 | Young Caroline | Purchase (P) | Common Stock | 6 | USD 3.45 | USD 21 | SEC filing ↗ |
| 2025-08-29 | Krogulski Kenneth | Purchase (P) | Common Stock | 68 | USD 3.45 | USD 235 | SEC filing ↗ |
| 2025-08-29 | KAZIMI A J | Purchase (P) | Common Stock | 13 | USD 3.45 | USD 45 | SEC filing ↗ |
| 2025-08-29 | Jones James | Purchase (P) | Common Stock | 13 | USD 3.45 | USD 45 | SEC filing ↗ |
| 2025-08-28 | Young Caroline | Purchase (P) | Common Stock | 6 | USD 3.47 | USD 21 | SEC filing ↗ |
| 2025-08-28 | Krogulski Kenneth | Purchase (P) | Common Stock | 68 | USD 3.47 | USD 236 | SEC filing ↗ |
| 2025-08-28 | KAZIMI A J | Purchase (P) | Common Stock | 13 | USD 3.47 | USD 45 | SEC filing ↗ |
| 2025-08-28 | Jones James | Purchase (P) | Common Stock | 13 | USD 3.47 | USD 45 | SEC filing ↗ |
| 2025-08-27 | Young Caroline | Purchase (P) | Common Stock | 6 | USD 3.44 | USD 21 | SEC filing ↗ |
| 2025-08-27 | Krogulski Kenneth | Purchase (P) | Common Stock | 68 | USD 3.44 | USD 234 | SEC filing ↗ |
| 2025-08-27 | KAZIMI A J | Purchase (P) | Common Stock | 13 | USD 3.44 | USD 45 | SEC filing ↗ |
| 2025-08-27 | Jones James | Purchase (P) | Common Stock | 13 | USD 3.44 | USD 45 | SEC filing ↗ |
| 2025-08-26 | Young Caroline | Purchase (P) | Common Stock | 6 | USD 3.39 | USD 20 | SEC filing ↗ |
| 2025-08-26 | Krogulski Kenneth | Purchase (P) | Common Stock | 68 | USD 3.39 | USD 231 | SEC filing ↗ |
| 2025-08-26 | KAZIMI A J | Purchase (P) | Common Stock | 13 | USD 3.39 | USD 44 | SEC filing ↗ |
Form 4 evidence
211 transaction lines in the latest 365-day window; 3,884 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-03-18 | Young Caroline | Award / grant (A) | Common Stock | 1,800 | USD 2.80 | USD 5,040 | SEC filing ↗ |
| 2026-03-18 | Krogulski Kenneth | Award / grant (A) | Common Stock | 5,800 | USD 2.80 | USD 16,240 | SEC filing ↗ |
| 2026-03-18 | Jones James | Award / grant (A) | Common Stock | 1,800 | USD 2.80 | USD 5,040 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-03-18 | Young Caroline | Award / grant (A) | Common Stock | 1,800 | USD 2.80 | USD 5,040 | SEC filing ↗ |
| 2026-03-18 | Krogulski Kenneth | Award / grant (A) | Common Stock | 5,800 | USD 2.80 | USD 16,240 | SEC filing ↗ |
| 2026-03-18 | Jones James | Award / grant (A) | Common Stock | 1,800 | USD 2.80 | USD 5,040 | SEC filing ↗ |
| 2026-03-18 | Galante Joseph C | Award / grant (A) | Common Stock | 1,800 | USD 2.80 | USD 5,040 | SEC filing ↗ |
| 2026-03-18 | Brown Martin S JR | Award / grant (A) | Common Stock | 1,800 | USD 2.80 | USD 5,040 | SEC filing ↗ |
| 2026-03-16 | KAZIMI A J | Tax withholding (F) | Common Stock | 5,845 | USD 3.06 | USD 17,886 | SEC filing ↗ |
| 2025-12-31 | Young Caroline | L (L) | Common Stock | 5 | USD 3.91 | USD 20 | SEC filing ↗ |
| 2025-12-31 | Krogulski Kenneth | L (L) | Common Stock | 62 | USD 3.91 | USD 242 | SEC filing ↗ |
| 2025-12-31 | KAZIMI A J | L (L) | Common Stock | 7 | USD 3.91 | USD 27 | SEC filing ↗ |
| 2025-12-31 | Jones James | L (L) | Common Stock | 7 | USD 3.91 | USD 27 | SEC filing ↗ |
| 2025-12-30 | Young Caroline | L (L) | Common Stock | 2 | USD 3.94 | USD 8 | SEC filing ↗ |
| 2025-12-30 | Krogulski Kenneth | L (L) | Common Stock | 54 | USD 3.94 | USD 213 | SEC filing ↗ |
| 2025-12-30 | KAZIMI A J | L (L) | Common Stock | 8 | USD 3.94 | USD 32 | SEC filing ↗ |
| 2025-12-30 | Jones James | L (L) | Common Stock | 8 | USD 3.94 | USD 32 | SEC filing ↗ |
| 2025-12-29 | Young Caroline | L (L) | Common Stock | 2 | USD 4.01 | USD 8 | SEC filing ↗ |
| 2025-12-29 | Krogulski Kenneth | L (L) | Common Stock | 54 | USD 4.01 | USD 217 | SEC filing ↗ |
| 2025-12-29 | KAZIMI A J | L (L) | Common Stock | 8 | USD 4.01 | USD 32 | SEC filing ↗ |
| 2025-12-29 | Jones James | L (L) | Common Stock | 8 | USD 4.01 | USD 32 | SEC filing ↗ |
| 2025-12-26 | Young Caroline | L (L) | Common Stock | 2 | USD 4.21 | USD 8 | SEC filing ↗ |
| 2025-12-26 | Krogulski Kenneth | L (L) | Common Stock | 54 | USD 4.21 | USD 227 | SEC filing ↗ |
| 2025-12-26 | KAZIMI A J | L (L) | Common Stock | 8 | USD 4.21 | USD 34 | SEC filing ↗ |
| 2025-12-26 | Jones James | L (L) | Common Stock | 8 | USD 4.21 | USD 34 | SEC filing ↗ |
| 2025-12-24 | Young Caroline | L (L) | Common Stock | 2 | USD 4.26 | USD 9 | SEC filing ↗ |
| 2025-12-24 | Krogulski Kenneth | L (L) | Common Stock | 54 | USD 4.26 | USD 230 | SEC filing ↗ |
| 2025-12-24 | KAZIMI A J | L (L) | Common Stock | 8 | USD 4.26 | USD 34 | SEC filing ↗ |
| 2025-12-24 | Jones James | L (L) | Common Stock | 8 | USD 4.26 | USD 34 | SEC filing ↗ |
| 2025-12-23 | Young Caroline | L (L) | Common Stock | 2 | USD 4.13 | USD 8 | SEC filing ↗ |
| 2025-12-23 | Krogulski Kenneth | L (L) | Common Stock | 54 | USD 4.13 | USD 223 | SEC filing ↗ |
| 2025-12-23 | KAZIMI A J | L (L) | Common Stock | 8 | USD 4.13 | USD 33 | SEC filing ↗ |
| 2025-12-23 | Jones James | L (L) | Common Stock | 8 | USD 4.13 | USD 33 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | CPIX |
| CIK | 0001087294 |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 3,884 transaction lines from 2020-03-18 to 2026-03-18 2,346 P purchase lines · 0 S sale lines · 1,538 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.